Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/199200
Title: Detección en urgencias de infección por VIH en pacientes que consultan por condiciones potencialmente relacionadas con infección oculta: resultados iniciales del programa "Urgències VIHgila"
Author: Miró i Andreu, Òscar
Miró, Emília
Ejarque Carbó, Miriam
Saura, Mireia
Rebollo, Alexis
De Paz, Rocío
Guardiola, Josep Maria
Smithson Amat, Alejandro
Iturriza, Daniel
Ramió Lluch, Cristina
Leey, Connie
Ferro, José Ignacio
Villamor Ordozgoiti, Alberto
Gené, Emili
Keywords: Urgències mèdiques
VIH (Virus)
Herpes zòster
Medical emergencies
HIV (Viruses)
Shingles (Disease)
Issue Date: 16-Jan-2023
Publisher: Sociedad Española de Quimioterapia
Abstract: Objective: To estimate the prevalence of unknown HIV infection in patients who consulted in hospital emergency services (ED) for conditions defined in the SEMES-GESIDA Consensus Document (DC), evaluate the efficiency of its im-plementation and investigate the efficiency of HIV serology determination in other conditions. Methods: Results were reviewed in 10 Catalan EDs for 12 months (July-21-June-22) after implementing CD recommendations: request HIV serology in case of suspected sexually transmitted infection, chemsex, post-exposure prophylaxis (PEP), mononucleosis syndrome, community pneumonia (18-65 y-o) or herpes zoster (18-65 y-o). Other reasons for request were included. Prevalence (%) of global seropositivity and for each circumstance was calculated, with a 95% confidence interval (95%CI). The efficient strategy was considered if the lower limit of the CI95%>0.1%. Results: A total of5,107 HIV serologies were performed: 2,847(56%) in situations specified in CD, and 2,266 (44%) in other 138 circumstances. Forty-eight unknown HIV infections were detected (prevalence=0.94%;95%CI=0.69-1.24). The prevalence was somewhat higher in DC requests (30 cas-es 1.12%) than the rest (18 cases 0.71%; p=0.16). The individualized prevalence of CD reasons ranged between 7.41% (95%CI=0.91-24.3) in chemsex and 0.42% 95%CI=0.14-0.98 in PPE, always efficient except herpes zoster (0.76%; CI95%=0.02-4.18). In other reasons, cases were detected in 12 circumstances, and in four the determination could be efficient: lymphopenia (10%;CI95%=0.25-44.5), fever with polyarthralgia-polyarthritis (7.41%;CI95% =0.91-24.3), behavioral alteration-confusion-encephalopathy (3.45%;95%CI=0.42-11.9) and fever of unknown origin (2.50%;95%CI=0.82-5.74). Conclusions: The determination of HIV serology in HES in the processes defined by DC SEMES-GESIDA is efficient. Some circumstances are identified that could be added to those previously contemplated to increase efficiency.
Note: Reproducció del document publicat a: https://doi.org/10.37201/req/085.2022
It is part of: Revista Espanola de Quimioterapia, 2023, vol. 36, num. 2, p. 169-179
URI: http://hdl.handle.net/2445/199200
Related resource: https://doi.org/10.37201/req/085.2022
ISSN: 0214-3429
Appears in Collections:Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
728541.pdf993.12 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.